Choosing an IVF Clinic Abroad: What Actually Matters
Key Takeaways
Choosing an IVF or ICSI clinic abroad is safer when judged by verifiable criteria rather than price or reviews alone: the embryology lab's quality standards, how success rates are actually reported (per cycle versus cumulative), what the legal framework requires, and whether recommended add-ons are evidence-based. None of these criteria depend on which country you compare — they apply to any clinic, anywhere.
Key evidence: ESHRE recommendations on good practice in the IVF laboratory (2026) ESHRE good practice recommendations on add-ons in reproductive medicine (2023)
Many patients looking into IVF or ICSI abroad begin by comparing countries. But country is not the most useful place to start: a well-run clinic and a poorly run one can be in the same city, sometimes on the same street.
What matters is whether the clinic can answer a few practical questions clearly and with evidence. Those questions apply wherever you are considering treatment, including close to home.
Why Price and Reviews Alone Aren’t Enough
Price tells you what is included in a quote, not how good the clinical care is. Online reviews cannot replace standards you can verify.
A lower quoted price can mean a leaner protocol that genuinely fits your case — or it can mean genetic testing, medication, and freezing show up on the bill later. A higher price does not guarantee a better laboratory, either.
Online reviews can tell you how someone experienced the service. They cannot tell you whether the embryology lab follows a documented quality system. That is why the questions below are worth asking before you book a flight.
Does the Embryology Lab Follow Verifiable Standards?
Ask whether the lab follows a documented quality-management system, not simply whether it is described as “modern” or “state of the art.”
The embryology laboratory manages several factors that can affect treatment — the fertilization method, incubation conditions, and how embryos are graded and selected for transfer.
The European Society of Human Reproduction and Embryology (ESHRE) publishes detailed good-practice recommendations covering staffing, quality management, laboratory safety, identification and traceability of gametes and embryos, and the specific procedures performed in an IVF lab, from oocyte retrieval through cryopreservation (ESHRE, Recommendations on Good Practice in the IVF Laboratory, 2026).
A clinic should be able to explain how identity checks work, how incubators are monitored, and which embryo-grading system it uses. Those details tell you far more than a marketing phrase. If the answer keeps returning to “modern equipment,” that is useful information too.
How Transparent Is the Success-Rate Reporting?
First ask whether the quoted success rate is per embryo transfer or cumulative across a full treatment plan. The two numbers are not comparable.
Success rates are among the easiest numbers to frame selectively in fertility marketing. A clinic may highlight a rate per embryo transfer in a favorable age group without stating the denominator, for example, even though the figure itself is technically correct.
The global registry consortium ICMART has pushed the field toward standardized definitions, in particular reporting the cumulative live-birth rate per aspiration — combining the outcome of a fresh transfer with any subsequent frozen embryo transfers from the same egg-collection cycle — because that number reflects what a patient actually experiences across a treatment plan, not a single transfer in isolation (Chambers et al., ICMART World Report: ART 2014, published 2021).
A clinic willing to state, in writing, how a quoted percentage was calculated — cycle type, age bracket, per-transfer or cumulative — is giving you a number you can actually use.
What Does the Legal Framework Allow — and Require?
Fertility law varies by country, including rules on marital status, gamete source, and third-party reproduction. Confirm what applies to you in writing before you travel, not after.
Some countries permit donor eggs or sperm and gestational surrogacy; others restrict treatment to a couple’s own gametes, or require proof of marriage. These rules are not a reflection of clinical quality in either direction — they are local law, and they determine what is even possible for your specific situation.
Ask the clinic to confirm, in writing, what applies to your case before you book travel, and verify independently through your destination country’s official health-regulation authority rather than relying on the clinic’s summary alone.
What’s Actually Included in the Cost Estimate?
A useful cost estimate separates the base cycle from items that are often billed separately.
A base IVF or ICSI quote may cover monitoring visits, egg retrieval, fertilization, and embryo culture through to a fresh transfer, but inclusions vary between clinics.
Stimulation medication (which varies by ovarian response), preimplantation genetic testing, embryo freezing and its annual storage, a frozen embryo transfer in a later cycle, and surgical sperm retrieval are commonly quoted — and billed — separately.
A detailed breakdown of what typically sits inside versus outside a base quote is worth reviewing before comparing any two clinics’ prices directly, since an apparently cheaper quote may simply exclude more line items.
How Many Days Should You Realistically Plan For?
A fresh cycle usually requires a longer stay than a frozen embryo transfer. Ask for a day-by-day estimate based on your protocol rather than a generic range.
The monitoring visits, egg retrieval, and fresh transfer typically require the longest single stay; a later frozen transfer is usually shorter.
A step-by-step walkthrough of a typical treatment timeline can help you judge whether the schedule proposed for your stimulation protocol is realistic.
What Happens if the First Cycle Doesn’t Work?
A cycle that does not succeed still provides clinical information. It is also a time when patients may feel especially vulnerable and unproven “add-ons” are often proposed.
ESHRE’s 2023 good-practice recommendations reviewed dozens of supplementary tests, treatments, and procedures marketed as add-ons in reproductive medicine — additional to standard care, usually at extra cost — and found that the overwhelming majority are supported only by low-quality evidence, professional experience, or consensus, not high-quality trial data (ESHRE, Good Practice Recommendations on Add-ons in Reproductive Medicine, 2023).
That does not mean every add-on is useless; some may make sense in a specific clinical situation. But if one is suggested after a failed cycle, the clinic should be able to explain why it fits your case rather than adding it routinely.
A structured review of what to check after a failed cycle, including your right to your own embryology records, covers this in more detail.
Clinical Note
The biggest number on a clinic’s homepage is rarely the most useful one. Ask what it actually measures, and be cautious if anyone offers a package or prediction before reviewing your medical file.
In my own practice, I tell patients this directly: “The largest number on a website is not the clinic’s most important feature. Ask first who that rate actually includes — which age group, your own eggs or not, PGT-tested embryos or not, pregnancy per transfer or live birth per patient who started treatment.”
A polished website, published patient stories, a fast-responding coordinator, or a bundled “guaranteed package” can all create a good first impression — none of it tells you anything about the embryology lab itself. What concerns me is when a standard package and a high success percentage are offered before anyone has reviewed the patient’s actual file in detail. If a 70% success rate is promised before your age, ovarian reserve, and prior attempts have even been reviewed, that is a marketing sentence, not a personalized medical estimate.
The question about the lab I wish patients asked more often is specific: “For my age and patient group, what share of mature eggs collected actually fertilize, what share of fertilized embryos reach the blastocyst stage, and how does the clinic routinely audit those numbers?”
Patients often ask about the incubator brand, time-lapse imaging, or photos of the lab. Yet equipment brand alone does not determine laboratory quality.
What matters more is the experience and continuity of the embryology team; control of temperature, pH, and air quality; a documented quality-assurance system; fertilization and blastocyst-development rates; post-thaw embryo survival; and identity checks that prevent sample mix-ups. Even the most expensive incubator is only as reliable as the team and system around it — and the honesty with which results are tracked.
The approach I consider premature is offering a broad “implantation package” after a single failed transfer — ERA and microbiome testing, NK-cell testing, intralipid or IVIG, corticosteroids, endometrial scratching, thrombophilia panels, sometimes an unindicated hysteroscopy.
Some of these may be worth considering in specific clinical situations, but one failed transfer, on its own, does not establish an immune or implantation problem in the uterus. What I tell a patient in that situation: an embryo not implanting does not necessarily mean something is wrong with your uterus. Let’s first review the embryo’s development, the age-related chance of a chromosomal issue, the lab process, the transfer technique, and the treatment as a whole — labelling one failed attempt with a new diagnosis right away usually adds a new worry and a new bill, not new information.
My overall approach: a good clinic is not the one performing the most add-on procedures. It is the one that can tell the difference between when further investigation is warranted, when the protocol should change, and when repeating a well-designed treatment plan may be reasonable.
— Dr. Senai Aksoy
At a Glance: A Clinic-Evaluation Checklist
The same questions apply to any clinic in any country. Use them as one consistent checklist when comparing your options.
| Question to ask | What a clear answer looks like | Why it matters |
|---|---|---|
| What quality-management system does the lab follow? | A specific, documented system — not “modern equipment” | Predicts consistency, not just capability |
| Is the success rate per transfer or cumulative? | A stated calculation method, with the denominator | The two numbers can differ substantially |
| What does local law require for your situation? | Written confirmation, verified independently | Determines what is legally possible at all |
| What is excluded from the base cost estimate? | A written, itemized list | Prevents cost surprises mid-treatment |
| How is an add-on after a failed cycle justified? | A case-specific clinical reason | Distinguishes evidence-based care from upselling |
Frequently Asked Questions
Is a more expensive clinic always a safer choice?
No. Price reflects what is included in a quote and local cost structures, not laboratory quality. Ask about the laboratory’s documented quality system and reporting standards directly rather than using price as a proxy for safety.
Can I ask to see a clinic’s actual embryology lab protocols?
You can ask how the lab documents its quality-management system, identity-witnessing process, and embryo-grading criteria. A clinic does not need to disclose proprietary detail to answer these questions in general terms.
Why do two clinics quote different success rates for what looks like the same procedure?
The rates are often calculated differently — per embryo transfer versus cumulative across a full treatment plan, or in different age brackets. Ask each clinic to state its calculation method and the population it applies to.
Are all reproductive medicine “add-ons” a waste of money?
Not necessarily, but most lack high-quality trial evidence and are not appropriate for every patient. A recommendation should come with a case-specific reason, not be offered as routine.
What should I do if my first cycle abroad fails?
Request your complete medical file, including embryology reports, before deciding on a next step. A meaningful second opinion depends on reviewing what actually happened in the previous cycle, not repeating the same protocol from a blank page.
Medical Disclaimer
This article is for general education and reflects guidance from professional societies alongside clinical experience. It is not an individual diagnosis, treatment recommendation, or promise of a particular outcome. A general framework cannot replace direct verification of a specific clinic or a review of your own medical circumstances.
Sources
- ESHRE IVF Labs Working Group. ESHRE recommendations on Good Practice in the IVF laboratory. Hum Reprod. 2026;41(8):1245-1269.
- ESHRE Add-ons working group. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062-2104.
- Chambers GM, Dyer S, Zegers-Hochschild F, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014. Hum Reprod. 2021;36(11):2921-2934.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.